Cel Sci (CVM) Other Non-Current Liabilities (2010 - 2026)
Cel Sci (CVM) reported Other Non-Current Liabilities of $125,000 for fiscal Q3 2026 (quarter ended Jun 30, 2026), unchanged from $125,000 a year earlier and unchanged from the prior quarter.
Cel Sci (CVM) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Dating back to fiscal Q4 2010, Cel Sci's Other Non-Current Liabilities record includes 51 quarters.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -48.8% (FY2020 to FY2025).
- By fiscal year, Other Non-Current Liabilities came in at $125,000 in FY2024 (unchanged), $125,000 in FY2023 (unchanged), $125,000 in FY2022 (unchanged) and $125,000 in FY2021 (-96.5%).
- The year-over-year decline in Other Non-Current Liabilities has ranged between 0.0% (fiscal Q3 2026) and 96.5% (fiscal Q4 2021) over the last five years.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $125,000 (Q2 2026), $125,000 (Q1 2026) and $125,000 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Cel Sci | 3.22 Mn | -22.43 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125,000.00 |
| Mar 31, 2026 | 125,000.00 |
| Dec 31, 2025 | 125,000.00 |
| Sep 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 125,000.00 |
| Mar 31, 2025 | 125,000.00 |
| Dec 31, 2024 | 125,000.00 |
| Sep 30, 2024 | 125,000.00 |
| Jun 30, 2024 | 125,000.00 |
| Mar 31, 2024 | 125,000.00 |
| Dec 31, 2023 | 125,000.00 |
| Sep 30, 2023 | 125,000.00 |
| Jun 30, 2023 | 125,000.00 |
| Mar 31, 2023 | 125,000.00 |
| Dec 31, 2022 | 125,000.00 |
| Sep 30, 2022 | 125,000.00 |
| Jun 30, 2022 | 125,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 125,000.00 |
Cel Sci Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CVM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();